Introduction: Who Should Undergo Diagnostics

Non-obstructive cardiomyopathy, particularly the non-obstructive form of hypertrophic cardiomyopathy, refers to a condition where the heart muscle becomes abnormally thick but does not physically block the flow of blood leaving the heart. This makes it different from the obstructive type, where thickened muscle tissue directly obstructs blood flow. Even though there is no blockage at rest, people with non-obstructive cardiomyopathy can still experience serious symptoms that affect their quality of life.^[2]

Anyone who experiences symptoms such as chest pain, shortness of breath, fainting spells, or a sensation of rapid or irregular heartbeats should seek medical attention promptly. These symptoms can occur during or after physical activity, but they may also appear during rest. Because many people with hypertrophic cardiomyopathy have few or no symptoms at all, it is especially important for individuals with a family history of the condition to undergo regular checkups. This disease is hereditary, meaning it can run in families due to genetic mutations passed from parents to children.^[3]

If a close family member has been diagnosed with hypertrophic cardiomyopathy, healthcare professionals typically recommend that all blood relatives get checked, even if they feel completely healthy. Early detection is crucial because some people may develop serious complications over time, including life-threatening irregular heartbeats or sudden cardiac arrest. Fainting after exercise, particularly in young people involved in sports like basketball or running, is a red flag that requires immediate medical evaluation.^[2]

It is advisable to seek diagnostics when symptoms interfere with daily activities, when there is a known family history of heart disease, or when unusual symptoms such as dizziness or chest discomfort occur repeatedly. Prompt diagnosis can help healthcare providers recommend appropriate lifestyle changes, medications, or monitoring plans to reduce the risk of severe outcomes.

Diagnostic Methods

Diagnosing non-obstructive cardiomyopathy involves a combination of medical history review, physical examination, and specialized tests. The goal is to determine if the heart muscle is thickened, assess how well the heart is functioning, and rule out other conditions that might cause similar symptoms.

Medical History and Physical Examination

The diagnostic process typically begins with a detailed discussion about symptoms, family medical history, and any past heart-related problems. A healthcare professional will listen to the heart using a device called a stethoscope. In people with hypertrophic cardiomyopathy, a heart murmur may be heard, which is an unusual sound caused by turbulent blood flow. This initial examination helps doctors decide which further tests are necessary.^[7]

Echocardiogram

An echocardiogram is one of the most commonly used tests for diagnosing hypertrophic cardiomyopathy. This test uses sound waves to create moving images of the heart, allowing doctors to see the structure and thickness of the heart muscle in real time. It helps identify whether the heart walls are thicker than normal and can show how well the heart chambers and valves are working. An echocardiogram can also reveal whether there is any obstruction in the pathway where blood exits the heart, which helps distinguish between obstructive and non-obstructive forms of the disease.^[7]

In some cases, a special type of echocardiogram called a stress echocardiogram may be performed. This involves imaging the heart while the patient exercises on a treadmill or stationary bike. Interestingly, some people who appear to have non-obstructive cardiomyopathy at rest may develop a significant obstruction during or after exercise, especially when standing upright. This finding can explain symptoms such as fainting or a drop in blood pressure after physical activity, and it highlights the importance of assessing the heart under different conditions.^[2]

Electrocardiogram (ECG or EKG)

An electrocardiogram, also known as an ECG or EKG, is a quick and painless test that measures the electrical activity of the heart. Small sticky patches called electrodes are placed on the chest, arms, and legs, and wires connect them to a machine that records the heart’s electrical signals. The ECG can detect irregular heartbeats, known as arrhythmias, and can show signs of heart muscle thickening. While it does not provide images of the heart, it gives valuable information about how the heart’s electrical system is functioning.^[7]

Holter Monitor

A Holter monitor is a small portable device worn for one or two days while going about normal activities. It continuously records the heart’s electrical activity, capturing any irregular rhythms that might not show up during a brief office visit. This extended monitoring is particularly useful for people who experience symptoms like palpitations or dizziness intermittently, as it can reveal patterns that help explain those symptoms.^[7]

Cardiac MRI

A cardiac magnetic resonance imaging (MRI) test uses powerful magnets and radio waves to create detailed pictures of the heart. This test is often performed alongside an echocardiogram to provide even more information about the heart muscle’s thickness, structure, and function. Cardiac MRI can detect areas of scarring or abnormal tissue within the heart muscle, which may increase the risk of dangerous arrhythmias. It is considered one of the most accurate imaging techniques for evaluating hypertrophic cardiomyopathy.^[7]

Exercise Stress Test

An exercise stress test involves walking on a treadmill or pedaling a stationary bike while the heart is monitored with an ECG. The intensity of exercise gradually increases to see how the heart responds to physical exertion. This test can reveal symptoms such as chest pain, shortness of breath, or abnormal heart rhythms that only appear during activity. It also helps doctors understand the patient’s exercise capacity and overall heart function under stress.^[7]

Genetic Testing

Because hypertrophic cardiomyopathy is often inherited, genetic testing may be recommended. This involves analyzing a blood sample to look for mutations in the genes responsible for heart muscle proteins. If a specific genetic mutation is found in one family member, other relatives can be tested for the same mutation to see if they are at risk of developing the disease. Genetic counseling is often part of this process to help families understand the implications of test results.^[7]

Cardiac Catheterization

In some cases, doctors may perform a cardiac catheterization, also known as an angiogram. This procedure involves inserting a thin, flexible tube called a catheter into a blood vessel, usually in the groin or wrist, and guiding it to the heart. A special dye is injected, and X-ray images are taken to see the coronary arteries and heart chambers in detail. While this test is more commonly used to detect blockages in the coronary arteries, it can also measure pressures within the heart and help assess the degree of any obstruction in the outflow tract.^[7]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies designed to test new treatments or medications for specific diseases. For people with non-obstructive hypertrophic cardiomyopathy, participating in a clinical trial may offer access to cutting-edge therapies that are not yet widely available. However, qualifying for a clinical trial requires meeting certain diagnostic criteria to ensure that the study results are accurate and meaningful.

Most clinical trials require participants to have a confirmed diagnosis of non-obstructive hypertrophic cardiomyopathy based on standard tests such as echocardiography and cardiac MRI. These imaging tests must show that the heart muscle is abnormally thick but that there is no significant obstruction in the left ventricular outflow tract at rest. Typically, a left ventricular outflow tract gradient (a measurement of pressure difference) of less than 30 millimeters of mercury (mmHg) is considered non-obstructive.^[10]

Patients enrolled in trials often undergo detailed assessments to measure their symptoms and functional capacity. One common test is a measurement of peak oxygen uptake, which evaluates how much oxygen the body can use during maximum physical exertion. This test helps researchers understand how the disease affects a person’s ability to exercise and perform daily activities. Blood tests may also be used to measure levels of certain proteins or markers that indicate heart stress or damage.^[10]

Researchers may also require participants to complete questionnaires that assess symptoms and quality of life. One example is the Kansas City Cardiomyopathy Questionnaire, which asks about symptoms such as shortness of breath, fatigue, and how these affect daily activities. These patient-reported outcomes help determine whether a new treatment improves not only medical measurements but also how people feel and function in everyday life.^[10]

In some trials, advanced imaging techniques such as echocardiography during exercise or special cardiac MRI scans are used to track changes in the heart over time. Blood samples may be collected at regular intervals to measure cardiac biomarkers, which are substances released into the bloodstream when the heart is under stress or damaged. These measurements help researchers assess whether a treatment is having a beneficial effect on the heart muscle itself.^[10]

Genetic testing may also be required or recommended for trial participation. Some clinical trials focus on patients with specific genetic mutations, while others aim to understand how different genetic backgrounds influence treatment responses. Knowing a patient’s genetic profile can help researchers develop more personalized and effective therapies in the future.

Before enrolling in a clinical trial, patients typically undergo a thorough screening process to confirm that they meet all eligibility criteria. This ensures that the study results are reliable and that participants are likely to benefit from or contribute meaningful data to the research. Potential participants should discuss the benefits and risks of trial participation with their healthcare team to make an informed decision.